Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

mRNA 3705

Next Previous
X
Search
Drug Profile

mRNA 3705

Alternative Names: mRNA-3705

Latest Information Update: 28 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Moderna Therapeutics
  • Class RNA
  • Mechanism of Action Methylmalonyl CoA mutase expression stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Methylmalonic acidaemia
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase I/II Methylmalonic acidaemia

Most Recent Events

  • 28 Oct 2024 No recent reports of development identified for preclinical development in Methylmalonic-acidaemia in USA (IV, Injection)
  • 12 Sep 2024 Interim pharmacodynamic and adverse event data from a phase I/II trial in Methylmalonic acidemia released by Moderna Therapeutics
  • 12 Jun 2024 mRNA 3705 receives Fast Track designation for Methylmalonic acidaemia [IV,Injection] (In adolescents, In children, In the elderly, In infants, In adults) in USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top